0000000000964604

AUTHOR

M.c. Lisanti

showing 3 related works from this author

247P Population-based testing for hereditary breast and ovarian cancer in a cohort of 1,346 patients from Southern Italy (Sicily): When historical ba…

2020

Oncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineCohortMedicineHematologyPopulation basedbusinessOvarian cancermedicine.diseaseAnnals of Oncology
researchProduct

1818P Body mass index (BMI) is not a cancer risk factor for BRCA1/2 carriers: A systematic review and meta-analysis of case-control studies

2021

Oncologymedicine.medical_specialtyText miningOncologybusiness.industryMeta-analysisInternal medicineCase-control studymedicineHematologyCancer risk factorbusinessBody mass indexAnnals of Oncology
researchProduct

20P Is evaluation of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutational status on circulating tumour DNA (ctD…

2021

Kinasebusiness.industryProtein subunitAlpha (ethology)HematologyMolecular biologychemistry.chemical_compoundOncologyPhosphatidylinositol 45-bisphosphatechemistryMutational statusMedicineLiquid biopsybusinessDNAAnnals of Oncology
researchProduct